The effect of acetylsalicylic acid on menstrual blood loss in women with IUDs

Pedrón, Nieves; Lozano, M; Gallegos, Alfredo J.

doi:10.1016/0010-7824(87)90099-0

Cited by 9 publications

(17 citation statements)

References 15 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Data regarding the overall safety of tranexamic acid are limited; an FDA warning states that tranexamic acid is contraindicated in women with active thromboembolic disease or with a history or intrinsic risk for thrombosis or thromboembolism (136,137). Treatment with aspirin demonstrated no statistically significant change in mean blood loss among women whose pretreatment menstrual blood loss was >80 ml or 60-80 mL; treatment resulted in a significant increase among women whose pretreatment menstrual blood loss was <60 mL (138). One study examined the use of a synthetic form of vasopressin, intranasal desmopressin (300 µg/day), for the first 5 days of menses for three treatment cycles and found a significant reduction in mean blood loss compared with baseline (130) (Level of evidence: I to II-3, poor to fair, direct).…”

Section: Bleeding Irregularities With Cu-iud Usementioning

confidence: 84%

U.S. Selected Practice Recommendations for Contraceptive Use, 2016

Curtis

Jatlaoui²,

Tepper³

et al. 2016

MMWR Recomm. Rep.

339

351

View full text Add to dashboard Cite

The 2016 U.S. Selected Practice Recommendations for Contraceptive Use (U.S. SPR) addresses a select group of common, yet sometimes controversial or complex, issues regarding initiation and use of specific contraceptive methods. These recommendations for health care providers were updated by CDC after review of the scientific evidence and consultation with national experts who met in Atlanta, Georgia, during August 26-28, 2015. The information in this report updates the 2013 U.S. SPR (CDC. U.S. selected practice recommendations for contraceptive use, 2013. MMWR 2013;62[No. RR-5]). Major updates include 1) revised recommendations for starting regular contraception after the use of emergency contraceptive pills and 2) new recommendations for the use of medications to ease insertion of intrauterine devices. The recommendations in this report are intended to serve as a source of clinical guidance for health care providers and provide evidence-based guidance to reduce medical barriers to contraception access and use. Health care providers should always consider the individual clinical circumstances of each person seeking family planning services. This report is not intended to be a substitute for professional medical advice for individual patients. Persons should seek advice from their health care providers when considering family planning options.

show abstract

Section: Bleeding Irregularities With Cu-iud Usementioning

confidence: 84%

U.S. Selected Practice Recommendations for Contraceptive Use, 2016

Curtis

Jatlaoui²,

Tepper³

et al. 2016

MMWR Recomm. Rep.

339

351

View full text Add to dashboard Cite

show abstract

“… 18 Aspirin has not been shown to be effective in decreasing menstrual blood loss in Cu-IUD users. 1 , 19 Limited evidence exists regarding use of intranasal desmopressin to decrease mean blood loss. 1 , 20 …”

Section: Copper-intrauterine Devicementioning

confidence: 99%

Unscheduled bleeding and contraceptive choice: increasing satisfaction and continuation rates

Villavicencio¹,

Allen²

2016

OAJC

View full text Add to dashboard Cite

Approximately half (51%) of the 6.6 million pregnancies in the US each year are unintended and half of those pregnancies (54%) occur among women not using contraception. Many women discontinue their contraceptives due to method dissatisfaction. Bothersome unscheduled bleeding is one of the main reasons cited by women for stopping a birth control method. Improving counseling and management of these side effects will aide in increasing satisfaction with contraceptive methods. The following review will discuss the bleeding profiles associated with the contraceptive options available in the US. A valuable resource from the Centers for Disease Control and Prevention, the US Selected Practice Recommendations for Contraceptive Use, will be introduced. Definitions of the types of unscheduled bleeding are included, as well as strategies for treatment for each contraceptive method. The evidence whether or not anticipatory counseling increases continuation rates will also be reviewed.

show abstract

“…In total, 742 records were identified by our database search, of which 607 potentially relevant unique articles were screened based on titles and abstracts ( Figure 1 ) [ 21 ]. Full-text screening was subsequently performed on 75 records, of which 13 studies were finally included [ [22] , [23] , [24] , [25] , [26] , [27] , [28] , [29] , [30] , [31] , [32] , [33] , [34] ]. Excluded studies and reasons for exclusion are listed in the Supplementary material (Item 16b of PRISMA 2020 checklist).…”

Section: Resultsmentioning

confidence: 99%

Effects of antiplatelet therapy on menstrual blood loss in reproductive-aged women: a systematic review

Kempers,

van der Zande,

Janssen

et al. 2024

Research and Practice in Thrombosis and Haemostasis

View full text Add to dashboard Cite

The effect of acetylsalicylic acid on menstrual blood loss in women with IUDs

Cited by 9 publications

References 15 publications

U.S. Selected Practice Recommendations for Contraceptive Use, 2016

U.S. Selected Practice Recommendations for Contraceptive Use, 2016

Unscheduled bleeding and contraceptive choice: increasing satisfaction and continuation rates

Effects of antiplatelet therapy on menstrual blood loss in reproductive-aged women: a systematic review

Contact Info

Product

Resources

About